Vote Scores

Home / Companies / Korro Bio, Inc. / 10 Jun 2026

Meeting · year to 30 June 2026160 filers reporting

Korro Bio, Inc.: meeting of 10 Jun 2026

Votes reported on Form N-PX, item by item

160 Form N-PX filers reported votes at the Korro Bio, Inc. meeting of 10 Jun 2026. Their records fall into 3 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

2 nominees; 43.9% of reported votes for; 35 filers withheld from or voted against at least one nominee.

172 vote records from 46 filers. 23 of the 46 filers that marked the item either way voted against management.

28.3% for0.0% against71.7% other50.0% against management46 filers
2

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on executive pay (say-on-pay)

221 vote records from 160 filers. 11 of the 153 filers that marked the item either way voted against management. 7 filers reported this item without a management mark.

87.5% for7.5% against5.0% other7.2% against management160 filers99.7% for0.3% against0.0% other0.3% against management8,854,927 reported shares
3

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

86 vote records from 46 filers. 0 of the 46 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management46 filers100.0% for0.0% against0.0% against management783,337 reported shares

How the largest families voted

Family1. Directors2. Say-on-pay3. Auditor
VanguardForForFor
BlackRock and iSharesAbstain or withhold *ForFor
FidelityForForFor
DimensionalAbstain or withhold *Against *For
State Street and SPDRSplit or no voteForFor
American CenturyAbstain or withhold *Against *For
InvescoNo reportAgainst *No report
EquitableAbstain or withhold *ForFor
Charles SchwabForForFor
Nuveen and TIAASplit or no voteForFor
ProShares and ProFundsAbstain or withhold *ForFor
John Hancock and ManulifeAbstain or withhold *ForFor
Morgan Stanley, Eaton Vance and CalvertAbstain or withhold *ForFor
J.P. MorganNo reportForNo report
Goldman SachsForForFor
PGIM and PrudentialNo reportForNo report
Northern Trust and FlexSharesSplit or no voteForFor
T. Rowe PriceSplit or no voteForFor
Lincoln FinancialSplit or no voteForFor
Russell InvestmentsNo reportForNo report
NationwideAbstain or withhold *ForFor
Guggenheim and RydexAbstain or withhold *ForFor
Columbia ThreadneedleSplit or no voteForFor
BNY MellonNo reportForNo report
PrincipalAbstain or withhold *ForFor
Pacific Life fundsAbstain or withhold *ForFor
Global XForForFor
AllianceBernsteinNo reportForNo report
DWSAbstain or withhold *ForFor
Neuberger BermanNo reportForNo report

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the Korro Bio, Inc. meeting?

160 Form N-PX filers reported votes at the meeting of 10 Jun 2026. On say-on-pay, 11 of 153 voted against management (7.2%). The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Korro Bio, Inc. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Korro Bio, Inc.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Korro Bio, Inc. with a meeting date within three days of 10 Jun 2026. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.